Results 61 to 70 of about 1,814 (132)

Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study

Clinical Ophthalmology, 2023
Debdulal Chakraborty,1 Milan Thakkar,2 Ramesh Venkatesh,3 Sangeeta Roy,4 Maulik Bhavsar,5 Helene Karcher6 1Disha Eye Hospital, Kolkata, West Bengal, India; 2Dr.
Chakraborty D, Thakkar M, Venkatesh R, Roy S, Bhavsar M, Karcher H   +5 more
doaj  

Efficacy of Intravitreal Brolucizumab Switch in Pachychoroid Neovasculopathy

Ophthalmology and Therapy
Introduction This study aimed to evaluate the anatomical and functional outcomes of switching to intravitreally administered brolucizumab (Beovu®, Novartis) in patients affected by pachychoroid neovasculopathy (PNV) who were considered as non-responders ...
Nicolò Ribarich, Marco Battista, Lisa Checchin, Riccardo Sacconi, Francesco Bandello, Giuseppe Querques   +5 more
doaj   +1 more source

Incidence of intraocular inflammation and its risk factors in patients treated with brolucizumab: a nationwide cohort study

Scientific Reports
This study aimed to evaluate the incidence of clinically significant intraocular inflammation (csIOI) after treatment with intravitreal injection (IVI) of brolucizumab and identify csIOI risk factors.
Hyo Song Park, Seung Won Lee, Hyunjin Park, Nang Kyeong Lee, Yong Joon Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim   +7 more
doaj   +1 more source

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry

Ophthalmology and Therapy
Introduction To assess real-world safety outcomes for adults with neovascular age-related macular degeneration (nAMD) treated with brolucizumab from the US-based IRIS® (Intelligent Research in Sight) Registry.
Marco A. Zarbin, Mathew W. MacCumber, Helene Karcher, Eser Adiguzel, Andrew Mayhook, Andrew LaPrise, Ver L. Bilano, Franklin Igwe, Michael S. Ip, Charles C. Wykoff   +9 more
doaj   +1 more source

Real-world evidence for brolucizumab efficacy in age-related macular degeneration and central serous chorioretinopathy patients

Heliyon
Real-world studies concerning different populations are valuable and bring new information regarding different regimens of Brolucizumab injections and their adverse reactions. The present study investigates the efficacy of a pro-re-nata regimen (PRN) for
Samoila Lacramioara, Samoila Ovidiu, Clichici Simona   +2 more
doaj   +1 more source

The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration

Ukrainian Journal of Ophthalmology
Aim. To evaluate the short-term efficacy of using a monoclonal antibody fragment (Brolucizumab) for treating neovascular age-related macular degeneration, depending on the morphometric parameters of the retina. Methods: This study included 48 patients
A. F. Yusupov, M. Kh. Karimova , S. A. Djamalova , D. K. Makhkamova , S. I. Abdullaeva , M. A. Zakirkhodjaeva, Z. A. Khodjaeva, D. A. Rakhimova   +7 more
doaj   +1 more source

Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Brolucizumab Injection in the Treatment of Diabetic Macular Edema with Hyperreflective Intraretinal Dots: A Retrospective Study

Clinical Ophthalmology
Somnath Chakraborty,1 Jay Umed Sheth2 1Department of Vitreoretinal Services, Retina Institute of Bengal, Siliguri, West Bengal, India; 2Department of Vitreoretinal Services, Shantilal Shanghvi Eye Institute, Mumbai, Maharashtra, IndiaCorrespondence ...
Chakraborty S, Sheth JU
doaj  

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration

International Medical Case Reports Journal, 2020
Jaycob Avaylon,1 Sol Lee,2 Ron P Gallemore2 1California Northstate University, College of Medicine, Elk Grove, CA, USA; 2Retina Macula Institute, Torrance, CA, USACorrespondence: Ron P GallemoreRetina Macula Institute, 4201 Torrance Blvd., Ste 220 ...
Avaylon J, Lee S, Gallemore RP
doaj  

Safety and Efficacy of Brolucizumab in the Treatment of Patients with Diabetic Macular Edema and Diabetic Retinopathy: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Bourisly SN, Semairan FS, Al-Shammari YM, Alali N, Alfoudari LA, Abdulkareem AF, Alharran AM.   +6 more
europepmc   +1 more source

Risk of intraocular hemorrhage among exudative age-related macular degeneration patients treated with different anti-VEGF agents. [PDF]

PLoS One
Kim MS, Nam S, Lee J, Woo SJ.
europepmc   +1 more source